AXID (2020-04-29)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
AXID 150 mg Capsules
| Lot or serial number | Companies | Brand name | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| 616927, 617088 | - Recalling Firm
- Pendopharm Division of Pharmascience Inc.
- SUITE 100 6111, Royalmount Avenue
- Montreal
- H4P 2T4
- Quebec
- CANADA
- Marketing Authorization Holder
- Pendopharm Division of Pharmascience Inc.
- SUITE 100 6111, Royalmount Avenue
- Montreal
- H4P 2T4
- Quebec
- CANADA
| AXID 150 mg Capsules | DIN 00778338 | Capsule | Nizatidine 150 mg |
Presence of N-nitrosodimethylamine (NDMA) near the interim acceptable concentration limit in affected lots
Wholesalers, Retailers, Healthcare establishments